|
USP30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.901900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.221300E-03 |
| Normal-vs-Stage2 |
3.057700E-02 |
| Normal-vs-Stage3 |
4.680800E-01 |
| Normal-vs-Stage4 |
3.428600E-01 |
| Stage1-vs-Stage2 |
8.354600E-01 |
| Stage1-vs-Stage3 |
2.693200E-01 |
| Stage1-vs-Stage4 |
9.186000E-01 |
| Stage2-vs-Stage3 |
4.550800E-01 |
| Stage2-vs-Stage4 |
9.951400E-01 |
| Stage3-vs-Stage4 |
6.378200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.676000E-03 |
| Normal-vs-AfricanAmerican |
2.785000E-01 |
| Normal-vs-Asian |
3.113400E-01 |
| Caucasian-vs-AfricanAmerican |
2.270600E-01 |
| Caucasian-vs-Asian |
8.611200E-01 |
| AfricanAmerican-vs-Asian |
8.076600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.837900E-03 |
| Normal-vs-Female |
1.555820E-01 |
| Male-vs-Female |
3.056400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.653700E-02 |
| Normal-vs-Extreme_Weight |
4.816200E-04 |
| Normal-vs-Obese |
1.285630E-01 |
| Normal-vs-Extreme_Obese |
2.804200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.220800E-01 |
| Normal_Weight-vs-Obese |
5.191600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.364600E-01 |
| Extreme_Weight-vs-Obese |
1.015370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.919400E-01 |
| Obese-vs-Extreme_Obese |
3.757800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.963400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.343610E-01 |
| Normal-vs-Age(61-80Yrs) |
4.419600E-04 |
| Normal-vs-Age(81-100Yrs) |
5.937800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.984400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.469800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.059800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.890100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.610000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.017500E-02 |
| Normal-VS-Type2 PRCC |
2.210100E-02 |
| Normal-VS-KIRP CIMP |
1.62510999999199E-05 |
| Normal-VS-Unclassified PRCC |
2.693000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.115000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.621700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.173000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.284100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.527400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.864250E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.365550E-02 |
| Normal-vs-N1 |
8.755800E-01 |
| Normal-vs-N2 |
7.993500E-02 |
| N0-vs-N1 |
2.995000E-01 |
| N0-vs-N2 |
7.281200E-01 |
| N1-vs-N2 |
5.199400E-01 |
|
|
